PCUK Nurse Jeni Posted January 25, 2013 Share Posted January 25, 2013 Hi,At the recent ASCO (American Society of Clinical Oncology) conference, announcements were made about the drug ABRAXANE (Nab-Paclitaxel) and its use in metastatic pancreatic cancer. Results of clinical trials showed some promising benefit from the drug, when combined with gemcitabine.You can read more about this here:http://www.pancreaticcancer.org.uk/about-us/media-centre/press-releases-and-comments/cancer-drug-extends-survival-in-patients-with-advanced-pancreatic-cancer-by-nearly-two-monthsWe look forward to hearing more about this, and in particular, its licencing for use in the UK.Support Team. Link to comment Share on other sites More sharing options...
Recommended Posts